文献速递细胞病理与分子病理血液淋巴病理

乳腺植入物相关间变性大细胞淋巴瘤与积液:细胞病理学作用的综述

Breast implant-associated anaplastic large cell lymphoma and effusions: A review with emphasis on the role of cytopathology.
PubMed 文献 · Cancer Cytopathol · 2020-01-03

本文综述乳腺植入物相关间变性大细胞淋巴瘤(BIA-ALCL)的细胞病理学诊断价值。BIA-ALCL多表现为迟发性积液,细胞学分析是快速可靠诊断的基石和金标准,NCCN指南强调其核心作用。文章总结反应性和恶性积液的细胞学发现,提出以非典型细胞为触发进一步辅助检查的全面细胞病理学流程。

要点

  • 迟发性乳腺植入物相关积液是BIA-ALCL最常见首发表现,细胞学分析为诊断金标准。
  • NCCN指南强调细胞病理学在BIA-ALCL诊断和管理中的关键作用。
  • 以非典型细胞为关键触发点,决定是否进行免疫细胞化学或流式细胞术等辅助检查。

核心结论

  • 细胞病理学分析是BIA-ALCL快速、高效、可靠诊断的基石和金标准,对适当管理至关重要。

研究设计与样本

  • 本文为综述,总结BIA-ALCL当前知识、乳腺植入物相关反应性和恶性积液的细胞学发现及细胞病理学工作流程。

主要发现

  • BIA-ALCL通常临床过程惰性,但部分具有不良特征的患者预后较差。
  • 迟发性乳腺植入物相关积液是BIA-ALCL最常见的初始表现。

关键数值与推荐

  • NCCN近期发布了BIA-ALCL诊断和管理临床指南,强调细胞病理学分析的必要作用。
  • 是否所有血清肿均应进行免疫细胞化学或流式细胞术(尤其评估CD30表达而不论细胞学形态)仍存争议。

临床怎么用

  • 对乳腺植入物相关积液进行细胞病理学分析以排除BIA-ALCL。
  • 以非典型细胞为关键触发元素,启动进一步辅助检查以确保适当且成本效益高的管理。

局限性

  • 是否所有血清肿均需免疫细胞化学或流式细胞术评估CD30仍存争议。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Breast implants are surgically implanted by the hundreds of thousands every year worldwide for reconstructive or aesthetic purposes. Complications related to breast implants include early and late effusions that are often submitted for cytopathological analysis, particularly to exclude the possibility of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), a rare disease that generally follows an indolent clinical course, although it is becoming clearer that a subset of patients with adverse features have a poorer prognosis. Since a late-onset breast implant-associated effusion is the most common initial presentation of BIA-ALCL, cytopathological analysis of these effusions is considered the cornerstone and gold standard for rapid, efficient, reliable diagnosis and is critical for appropriate management and treatment. The National Comprehensive Cancer Network recently published clinical guidelines for the diagnosis and management of BIA-ALCL and stresses the essential role of cytopathological analysis, although it remains a matter of debate if all seromas should undergo immunocytochemistry or flow cytometry, particularly for assessment of expression of CD30 irrespective of morphological appearance on cytology. Herein, we review the current knowledge on BIA-ALCL, review the key cytological findings of reactive and malignant effusions related to breast implants, and present a comprehensive cytopathological workup with the presence of atypical cells as the key and pivotal element triggering further ancillary studies. We believe this approach will ensure appropriate and cost-effective management of effusion specimens from breast implants.

来源:Cancer Cytopathol,查看原文。版权归原作者所有。

引用

  1. Julien LA, Michel RP, Auger M, et al. Breast implant-associated anaplastic large cell lymphoma and effusions: A review with emphasis on the role of cytopathology. Cancer Cytopathol. 2020. PMID: 31899606. doi:10.1002/cncy.22233

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。